Position in ATRA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,479
+$1,458 QoQ
Shares Held
216
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 36 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in ATRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. ATRA ranks #350 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in ATRA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,479 | 216 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,021 | 216 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,907 | 216 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,095 | 216 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $1,667 | 216 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,283 | 216 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,874 | 216 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $11,138 | 1,370 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $14,110 | 1,660 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $937,743 | 1,351,216 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,122,464 | 2,188,044 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $12,828,037 | 8,667,594 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $12,429,606 | 7,720,253 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $22,201,728 | 7,655,769 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $24,598,145 | 7,499,435 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $31,311,205 | 8,283,388 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $69,029,152 | 8,861,252 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $76,084,160 | 8,189,899 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $116,893,841 | 7,417,122 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $143,483,122 | 8,015,817 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $116,851,437 | 7,514,562 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $96,332,220 | 6,708,372 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $121,858,465 | 6,207,767 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $72,299,626 | 5,578,675 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $60,538,785 | 4,155,030 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $24,425,809 | 2,870,248 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||